Effects of PERMISSive Lung-protective Ventilation on Outcome in Critically Ill Invasively Ventilated Patients

Recruiting N/A Interventional Study
Mechanical Ventilation Intensive Care (ICU)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
56 (estimated)
Sponsor
Reinier de Graaf Groep · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
RATIONALE Lung-protective ventilation using a lower respiratory rate (RR) is an appealing strategy to reduce ventilation intensity, which may require permissive hypercapnia. However, the feasibility and safety of this so-called 'permissive lung-protective ventilation' must be investigated, before conducting a large randomized clinical trial to evaluate its effectiveness on patient-centered outcome…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * admission to one of the participating ICUs; * intubated and receiving invasive ventilation with an expected duration of ventilation of at least 24 hours. Exclusion Criteria: * age below 18 years; * receiving invasive ventilation \> 1 hour in the ICU, or receiving invasive ve…
Contacts

Laura A. Buiteman-Kruizinga, RN, PhD

+31152604040

l.kruizinga@rdgg.nl

CONTACT